Introduction of a Quality Management System and Outcome After Hematopoietic Stem-Cell Transplantation
Aloïs Gratwohl, Jane F. Apperley(Hammersmith Hospital), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Helen Baldomero(University Hospital of Basel), Fiona E. J. McDonald(The University of Sydney), Dietger Niederwieser(Leipzig University of Applied Sciences), Christian Chabannon(Inserm), Jan J. Cornelissen(Erasmus MC), Eoin McGrath(European Molecular Biology Laboratory), Ineke Slaper‐Cortenbach(Maine Farmland Trust), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Per Ljungman(Karolinska University Hospital), André Tichelli(University Hospital of Basel), Théo de Witte(Radboud University Nijmegen), Jakob Passweg(University Hospital of Basel), Ronald Brand(Universität Hamburg), Vanderson Rocha(Fundação Pró-Sangue Hemocentro de São Paulo)
Cited by 102
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k